Standout Papers

Practice parameter: Evidence-based guidelines for migraine headache (an evidence-... 1996 2026 2006 2016 1.0k
  1. Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) [RETIRED] (2000)
    Stephen D. Silberstein Neurology
  2. OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program (2010)
    David W. Dodick, Catherine C. Turkel et al. Headache The Journal of Head and Face Pain
  3. Fremanezumab for the Preventive Treatment of Chronic Migraine (2017)
    Stephen D. Silberstein, David W. Dodick et al. New England Journal of Medicine
  4. Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial (2017)
    Stewart J. Tepper, Messoud Ashina et al. The Lancet Neurology
  5. Classification of daily and near-daily headaches (1996)
    Stephen D. Silberstein, Richard B. Lipton et al. Neurology
  6. The Acute Treatment of Migraine in Adults: The A merican H eadache S ociety Evidence Assessment of Migraine Pharmacotherapies (2015)
    Michael J. Marmura, Stephen D. Silberstein et al. Headache The Journal of Head and Face Pain
  7. Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine (2018)
    David W. Dodick, Stephen D. Silberstein et al. JAMA
  8. Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults (2018)
    Cristina Tassorelli, Hans‐Christoph Diener et al. Cephalalgia
  9. Marihuana: Studies on the Disposition and Metabolism of Delta-9-Tetrahydrocannabinol in Man (1970)
    Louis Lemberger, Stephen D. Silberstein et al. Science

Immediate Impact

7 by Nobel laureates 22 from Science/Nature 115 standout
Sub-graph 1 of 18

Citing Papers

Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial
2023 Standout
CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond
2022 Standout
297 intermediate papers

Works of Stephen D. Silberstein being referenced

Novel Medications for the Treatment of Migraine
2019
Pharmacological Approaches to Managing Migraine and Associated Comorbidities—Clinical Considerations for Monotherapy Versus Polytherapy
2007
and 144 more

Author Peers

Author Last Decade Papers Cites
Stephen D. Silberstein 20708 13188 9332 426 25.2k
David W. Dodick 22431 14568 9024 526 27.5k
Michel D. Ferrari 21217 10711 7471 522 29.0k
Messoud Ashina 15761 8813 6113 428 18.9k
Rigmor Jensen 12942 7638 6198 395 18.4k
Marcelo E. Bigal 14785 8648 5327 268 16.9k
Giuseppe Nappi 9559 5169 5602 595 19.2k
Rami Burstein 14171 7524 6922 192 18.2k
Lars Edvinsson 16686 9955 13288 958 40.6k
Zaza Katsarava 10201 6741 4077 231 12.7k
Michel Lantéri‐Minet 6558 4454 5922 234 13.4k

All Works

Loading papers...

Rankless by CCL
2026